Report Feature
Stem Cell Assay Market Trends and Forecast
The future of the global stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes. The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of 19.1% from 2023 to 2028. The major drivers for this market are increasing awareness of the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Stem Cell Assay Market by Segment
The study includes trends and forecast for the global stem cell assay market by type, cell type, product & service, application, end use industry, and region, as follows:
Stem Cell Assay Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Viability or Cytotoxicity
- Isolation and Purification
- Cell Identification
- Proliferation
- Differentiation
- Function
- Apoptosis
- Others
Stem Cell Assay Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Adult
- Mesenchymal
- Induced Pluripotent
- Hematopoietic
- Umbilical Cord
- Neural
- Human Embryonic
Stem Cell Assay Market by Product & Service [Value ($B) Shipment Analysis from 2017 to 2028]:
- Instruments
- Flow Cytometers
- Microelectrode Arrays
- Cell Imaging & Analysis Systems
- Automated Cell Counters
- Kits
- Services
Stem Cell Assay Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
- Regenerative Medicine & Therapy Development
- Orthopedic, Musculoskeletal, and Spine Application
- Dermatology Application
- Cardiovascular Application
- CNS Application
- Oncology Application
- Diabetes Application
- Drug Discovery & Development
- Clinical Research
Stem Cell Assay Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
- Biopharmaceutical & Biotechnology Companies
- Academic & Research Institutes
Stem Cell Assay Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Stem Cell Assay Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, stem cell assay companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell assay companies profiled in this report include-
- Thermo Fisher Scientific
- Merck KGaA
- Danaher
- Becton, Dickinson and Company
- Agilent Technologies
- Bio-Techne Corporation
- Lonza Group
- PerkinElmer
- Cell Biolabs
- Bio-Rad Laboratories
Stem Cell Assay Market Insights
- Lucintel forecasts that viability/cytotoxicity assay will remain the largest type segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
- Within this market, the biopharmaceutical & biotechnology companies segment is expected to record the highest growth due to growing prevalence of chronic diseases, an increase in the number of clinical trials, and growing strategic activities along with improvements in healthcare services.
- North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.
Features of the Stem Cell Assay Market
- Market Size Estimates: Stem cell assay market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Stem cell assay market size by various segments, such as by type, cell type, product & service, application, end use industry, and region
- Regional Analysis: Stem cell assay market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different by type, cell type, product & service, application, end use industry, and regions for the stem cell assay market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the stem cell assay market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the stem cell assay market size?
Answer: The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for stem cell assay market?
Answer: The global stem cell assay market is expected to grow with a CAGR of 19.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the stem cell assay market?
Answer: The major drivers for this market are increasing awareness about the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.
Q4. What are the major segments for stem cell assay market?
Answer: The future of the stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes.
Q5. Who are the key stem cell assay companies?
Answer: Some of the key stem cell assay companies are as follows:
Answer: The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for stem cell assay market?
Answer: The global stem cell assay market is expected to grow with a CAGR of 19.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the stem cell assay market?
Answer: The major drivers for this market are increasing awareness about the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.
Q4. What are the major segments for stem cell assay market?
Answer: The future of the stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes.
Q5. Who are the key stem cell assay companies?
Answer: Some of the key stem cell assay companies are as follows:
- Thermo Fisher Scientific
- Merck KGaA
- Danaher
- Becton, Dickinson and Company
- Agilent Technologies
- Bio-Techne Corporation
- Lonza Group
- PerkinElmer
- Cell Biolabs
- Bio-Rad Laboratories
Q6. Which stem cell assay segment will be the largest in future?
Answer: Lucintel forecasts that viability/cytotoxicity assay will remain the largest segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
Q7. In stem cell assay market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Answer: Lucintel forecasts that viability/cytotoxicity assay will remain the largest segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
Q7. In stem cell assay market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
